한국임상수의학회지 (Journal of Veterinary Clinics)

  • 제28권1호
  • /
  • Pages.139-143
  • /
  • 2011
  • /
  • 1598-298X(pISSN)
  • /
  • 2384-0749(eISSN)
한국임상수의학회 (The Korean Society of Veterinary Clinics)
권호 표지

개의 당뇨병에서 Insulin Glargine의 적용 2례

Use of Insulin Glargine in 2 Dogs with Diabetes Mellitus

  • 안진옥 (서울대학교 수의과대학 내과학교실.BK21 수의과학연구인력양성사업단) ;
  • 서경원 (서울대학교 수의과대학 내과학교실.BK21 수의과학연구인력양성사업단) ;
  • 황철용 (서울대학교 수의과대학 내과학교실.BK21 수의과학연구인력양성사업단) ;
  • 윤화영 (서울대학교 수의과대학 내과학교실.BK21 수의과학연구인력양성사업단)
  • Ahn, Jin-Ok (Department of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University and BK21 Program for Veterinary Science) ;
  • Seo, Kyoung-Won (Department of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University and BK21 Program for Veterinary Science) ;
  • Hwang, Cheol-Yong (Department of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University and BK21 Program for Veterinary Science) ;
  • Youn, Hwa-Young (Department of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University and BK21 Program for Veterinary Science)
  • 심사 : 2010.09.27
  • 발행 : 2011.02.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

A Spitz (5-years old, castrated male) and a Maltese (9-years old, castrated male) were presented with weight loss, polyuria/polydipsia (PU/PD) and depression. Diabetic ketosis was diagnosed based on clinical signs, physical examinations and screening tests (CBC, serum chemistry and urinalysis). The dogs were treated with NPH initially. However, NPH was inadequate to control blood glucose level due to the short duration of the action (< 5 hours). Because of the poor glycemic control with NPH, the dogs showed diabetic complications including weight loss and cataract. After change to glargine, the duration of insulin action was extended up to 11 hours. As a result, there was significant improvement in clinical signs and serum fructosamine concentrations. This study suggests that glargine is useful as a long-acting insulin in dogs which have poor glycemic control due to the short duration of NPH.

키워드

참고문헌

  1. Barnett AH. A review of basal insulin. Diabet Med 2003; 20: 873-885.
  2. Bolli GB, Di Marchi RD, Park GD, Pramming S, Koivisto VA. Insulin analogues and their potential in the management of diabetes mellitus. Diabetologia 1999; 42: 1151-1167. https://doi.org/10.1007/s001250051286
  3. Feldman EC, Nelson RM. Canine diabetes mellitus. In: Canine and Feline Endocrinology and Reproduction, 3rd ed. Philadelphia WB Saunders 2004: 486-538.
  4. Foster DW. Diabetes mellitus. In: Harrison's Principles of internal medicine, 12th ed. McGraw Hill Professional, 1991: 1739-1753.
  5. Guptill L, Glickman L, Glickman N. Time Trends and Risk Factors for Diabetes Mellitus in Dogs: Analysis of Veterinary Medical Data Base Records (1970-1999). Vet J 2003; 165: 240-247. https://doi.org/10.1016/S1090-0233(02)00242-3
  6. Hall TD, Mahony O, Rozanski EA, Freeman LM. Effects of diet on glucose control in cats with diabetes mellitus treated with twice daily insulin glargine. J Feline Med Surg 2009; 11: 125-130. https://doi.org/10.1016/j.jfms.2008.06.009
  7. Heinemann L, Linkeschova R, Rare K, Rave K, Hompesch B, Sedlak M, Heise T. Time action profile of the long acting insulin analogue insulin glargine(HOE901) in comparison with those of NPH insulin, and placebo. Diabetes Care 2000; 23: 644-649. https://doi.org/10.2337/diacare.23.5.644
  8. Hess R, Ward C. Effect of insulin dosage on glycemic response in dogs with diabetes mellitus: 221 cases (1993-1998). J Am Vet Med Assoc 2000; 216: 217-221. https://doi.org/10.2460/javma.2000.216.217
  9. Marshall RD, Rand JS, Morton JM. Insulin glargine has a long duration of effect following administration either once daily or twice daily in divided doses in healthy cats. J Feline Med Surg 2008; 10: 488-494. https://doi.org/10.1016/j.jfms.2008.05.002
  10. Monroe WE. Canine diabetes mellitus. In: Kirk's current veterinary therapy, 14th ed. St. Louis: Elsevier Saunders, 2009: 196-199.
  11. Mori A, Sako T, Lee P, Motoike T, Iwase K, Kanaya Y, Fukuta H, Mizutani H, Arai T. Comparison of time-action profiles of insulin Glargine and NPH insulin in normal and diabetic dogs. Vet Res Commun 2008; 32: 563-573. https://doi.org/10.1007/s11259-008-9059-5
  12. Nelson RW. Canine diabetes mellitus. In: Manual of canine and feline endocrinology, 3rd ed. Gloucester: British Small Animal Veterinary Association, 2004: 112-128.
  13. Nelson RW. Diabetes mellitus in dogs. In: Textbook of small animal internal medicine, 4th ed. St. Louis: Mosby, 2009: 767-785.
  14. Nelson RW. Diabetes mellitus. In: Textbook of veterinary internal medicine, 6th ed. St. Louis: Elsevier Saunders, 2005: 1563-1591.
  15. Palm CA, Boston RC, Refsal KR, Hess RS. An investigation of the action of Neutral Protamine Hagedorn human analogue insulin in dogs with naturally occurring diabetes mellitus. J Vet Intern Med 2009; 23: 50-55. https://doi.org/10.1111/j.1939-1676.2008.0249.x
  16. Rand J. Editorial: Glargine, a new long-acting insulin analog for diabetic cats. J Vet Intern Med 2006; 20: 219-220. https://doi.org/10.1111/j.1939-1676.2006.tb02848.x
  17. Scholtz HE, Pretorius SG, Wessels DH, Becker RH. Pharmacokinetic and glucodynamic variability: Assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique. Diabetologia 2005; 48: 1988. https://doi.org/10.1007/s00125-005-1916-y
  18. Weaver KE, Rozanski EA, Mahony OM, Chan DL, Freeman LM. Use of glargine and lente insulins in cats with diabetes mellitus. J Vet Intern Med 2006; 20: 234-238. https://doi.org/10.1111/j.1939-1676.2006.tb02851.x